Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TScan Therapeutics (TCRX)
NASDAQ:TCRX
RESEARCH TOOLSreports
Holding TCRX?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 27, 2024 | Barbara Klencke Director | xxxxxxxxxxxxx | $56100 |
| Aug 27, 2024 | Zoran Zdraveski Chief Legal And Strategy Officer | xxxxxxxxxxxxx | $951885 |
| Dec 21, 2023 | Timothy Barberich Director | xxxxxxxxxxxxx | $142263 |
| Dec 18, 2023 | Barbara Klencke Director | xxxxxxxxxxxxx | $25400 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $956428 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,784,792 | Institution | 5.72% | 15,372,052 | |
| 2,116,457 | Institution | 4.35% | 11,682,843 | |
| 1,836,546 | Institution | 3.77% | 10,137,734 | |
| 1,454,791 | Institution | 2.99% | 8,030,446 | |
| 1,046,916 | Institution | 2.15% | 5,778,976 | |
| 681,015 | Institution | 1.40% | 3,759,203 | |
| 479,187 | Institution | 0.98% | 2,645,110 | |
| 372,714 | Institution | 0.77% | 2,057,381 | |
| 163,492 | Institution | 0.34% | 902,476 | |
| 38,300 | Institution | 0.08% | 211,416 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,836,546 | Institution | 3.77% | 10,137,734 | |
| 681,015 | Institution | 1.40% | 3,759,203 | |
| 372,714 | Institution | 0.77% | 2,057,381 | |
| 38,300 | Institution | 0.08% | 211,416 | |
| 29,605 | Institution | 0.06% | 163,420 | |
| 27,590 | Institution | 0.06% | 152,297 | |
| 22,104 | Institution | 0.05% | 122,014 | |
| 10,788 | Institution | 0.02% | 59,550 | |
| 8,757 | Institution | 0.02% | 48,339 | |
| 6,233 | Institution | 0.01% | 34,406 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,299,924 | Institution | 2.67% | 9,281,457 | |
| 1,046,916 | Institution | 2.15% | 5,778,976 | |
| 998,167 | Institution | 2.05% | 5,509,882 | |
| 629,878 | Institution | 1.29% | 4,497,329 | |
| 476,278 | Institution | 0.98% | 2,629,055 | |
| 219,414 | Institution | 0.45% | 1,211,165 | |
| 150,761 | Institution | 0.31% | 1,076,434 | |
| 127,037 | Institution | 0.26% | 701,244 | |
| 89,457 | Institution | 0.18% | 493,803 | |
| 24,020 | Institution | 0.05% | 171,503 |
FAQ
Who Owns TScan Therapeutics (TCRX)?
Currently, no data Available
What percentage of TScan Therapeutics (TCRX) stock is held by institutional investors?
Currently, no data Available
What percentage of TScan Therapeutics (TCRX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of TScan Therapeutics (TCRX)?
Felix Baker owns the most shares of TScan Therapeutics (TCRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.